New Zealand markets closed

Dr. Reddy's Laboratories Limited (RDY)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
68.62-0.68 (-0.98%)
As of 10:38AM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

Currency in INR. All numbers in thousands
Breakdown
ttm
31/03/2023
31/03/2022
31/03/2021
Cash flows from operating activities
Net income
55,779,000
45,067,000
23,568,000
17,238,000
Depreciation & amortisation
14,700,000
12,636,000
11,824,000
12,796,000
Deferred income taxes
-
15,300,000
8,730,000
9,175,000
Stock-based compensation
407,000
397,000
592,000
584,000
Change in working capital
-20,182,000
-7,855,000
-18,498,000
-10,718,000
Accounts receivable
-8,054,000
-
-
-
Inventory
-18,445,000
-2,654,000
-9,912,000
-12,402,000
Accounts payable
3,460,000
-
-
-
Other working capital
17,998,000
40,009,000
9,059,000
23,142,000
Other non-cash items
-567,000
248,000
-7,000
144,000
Net cash provided by operating activities
45,433,000
58,875,000
28,108,000
35,703,000
Cash flows from investing activities
Investments in property, plant and equipment
-27,435,000
-18,866,000
-19,049,000
-12,561,000
Acquisitions, net
-12,000
0
-326,000
-15,514,000
Purchases of investments
-145,488,000
-136,171,000
-88,972,000
-75,418,000
Sales/maturities of investments
129,784,000
112,805,000
77,771,000
79,528,000
Net cash used for investing activities
-40,283,000
-41,373,000
-26,387,000
-22,660,000
Cash flows from financing activities
Debt repayment
-4,947,000
-20,397,000
-785,000
-4,497,000
Common stock issued
805,000
368,000
334,000
269,000
Common stock repurchased
-
-
0
-1,193,000
Dividends paid
-6,648,000
-4,979,000
-4,146,000
-4,147,000
Net cash used provided by (used for) financing activities
-3,763,000
-26,861,000
-2,422,000
-298,000
Net change in cash
1,387,000
-9,359,000
-701,000
12,745,000
Cash at beginning of period
5,779,000
14,852,000
14,820,000
1,962,000
Cash at end of period
7,107,000
5,779,000
14,852,000
14,820,000
Free cash flow
Operating cash flow
45,433,000
58,875,000
28,108,000
35,703,000
Capital expenditure
-27,435,000
-18,866,000
-19,049,000
-12,561,000
Free cash flow
17,998,000
40,009,000
9,059,000
23,142,000